These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15600264)

  • 1. Homocysteine and vascular access thrombosis in a cohort of end-stage renal disease patients.
    Bowden RG; Wyatt FB; Wilson R; Wilborn C; Gentile M
    Ren Fail; 2004 Nov; 26(6):709-14. PubMed ID: 15600264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and vascular access thrombosis in end-stage renal disease patients: a retrospective study.
    Bowden RG; Wyatt FB; Wilson R
    J Nephrol; 2002; 15(6):666-70. PubMed ID: 12495281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study.
    Saifan C; El-Charabaty E; El-Sayegh S
    Vasc Health Risk Manag; 2013; 9():361-4. PubMed ID: 23898227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship.
    Sirrs S; Duncan L; Djurdjev O; Nussbaumer G; Ganz G; Frohlich J; Levin A
    Nephrol Dial Transplant; 1999 Mar; 14(3):738-43. PubMed ID: 10193830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein predicts vascular access thrombosis in hemodialysis patients.
    Chou CY; Kuo HL; Yung YF; Liu YL; Huang CC
    Blood Purif; 2006; 24(4):342-6. PubMed ID: 16601326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis.
    Puskar D; Pasini J; Savić I; Bedalov G; Sonicki Z
    Croat Med J; 2002 Jun; 43(3):306-11. PubMed ID: 12035137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and vascular access thrombosis in hemodialysis patients.
    Hojs R; Gorenjak M; Ekart R; Dvorsak B; Pecovnik-Balon B
    Ren Fail; 2002 Mar; 24(2):215-22. PubMed ID: 12071595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis.
    Shafi ST; Gupta M
    J Vasc Access; 2007; 8(2):103-8. PubMed ID: 17534796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet adhesion testing may predict early hemodialysis arteriovenous graft and fistula failure in end-stage renal disease patients.
    ElChoufani SE; Bolin P; Waien S; Christiano CR; Holbert D; Bode AP
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):399-409. PubMed ID: 18160614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arteriovenous fistulas for hemodialysis. Patency rates and complications.
    Karabay O; Yetkin U; Onol H
    Saudi Med J; 2004 Oct; 25(10):1518-20. PubMed ID: 15494845
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients.
    Mallamaci F; Bonanno G; Seminara G; Rapisarda F; Fatuzzo P; Candela V; Scudo P; Spoto B; Testa A; Tripepi G; Tech S; Zoccali C
    Am J Kidney Dis; 2005 Apr; 45(4):702-7. PubMed ID: 15806473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access.
    Fitzgerald JT; Schanzer A; Chin AI; McVicar JP; Perez RV; Troppmann C
    Arch Surg; 2004 Feb; 139(2):201-8. PubMed ID: 14769581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation linked to vascular access thrombosis in chronic hemodialysis patients.
    Chou CY; Chen JY; Liu JH; Liu YL; Lin HH; Yang YF; Wang SM; Kuo HL; Huang CC
    J Atheroscler Thromb; 2011; 18(6):448-53. PubMed ID: 21368450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
    Vrentzos GE; Papadakis JA; Vardakis KE; Maliaraki N; Stilianou K; Arvanitis A; Sratigis S; Alivanis P; Margioris AN; Ganotakis ES
    J Nephrol; 2003; 16(4):535-9. PubMed ID: 14696755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma total homocysteine and hemodialysis access thrombosis: a prospective study.
    Shemin D; Lapane KL; Bausserman L; Kanaan E; Kahn S; Dworkin L; Bostom AG
    J Am Soc Nephrol; 1999 May; 10(5):1095-9. PubMed ID: 10232697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study.
    Chen TC; Wang IK; Lee CH; Chang HW; Chiou TT; Lee CT; Fang JT; Wu MS; Hsu KT; Yang CC; Wang PH; Chuang FR
    Int J Clin Pract; 2006 Dec; 60(12):1596-9. PubMed ID: 16704682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein.
    Busch M; Franke S; Müller A; Wolf M; Gerth J; Ott U; Niwa T; Stein G
    Kidney Int; 2004 Jul; 66(1):338-47. PubMed ID: 15200442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
    Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
    Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis Arteriovenous Vascular Access Creation After Kidney Transplant Failure.
    Zhang JC; Al-Jaishi A; Perl J; Garg AX; Moist LM
    Am J Kidney Dis; 2015 Oct; 66(4):646-54. PubMed ID: 25975965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.